BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Coagulation, Inflammatory disorder, Neuron, Holistic medicine, Valproic acid, SNCA)
Bookmark Forward

QuickView for UBE3A (gene)


Body Atlas

Most Correlated Tissues

  1. Skeletal muscle
  2. Heart ventricle
  3. Dendritic (plasmacytoid) cell
  4. Heart atrium
  5. Jejunum
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Angelman syndrome
  2. Pyloric ulcer
  3. Infectious disease of lung
  4. Lower respiratory tract infection
  5. Dehydration
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. N-(2,4-dichloro-5-(4-(difluoromethyl)-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl)phenyl)methanesulfonamide
  2. Apomorphine
  3. cyhalofop-butyl
  4. sodium selenate
  5. naphthalene
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. Mir181b1
  2. NDE1
  3. NCL
  4. MGMT
  5. ADGRG2
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. UBE3A controls axon initial segment in the cortical pyramidal neurons.
  2. A high sensitivity assay of UBE3A ubiquitin ligase activity.
  3. mRNA nuclear retention reduces AMPAR expression and promotes autistic behavior in UBE3A-overexpressi…
  4. Ube3a unsilencer for the potential treatment of Angelman syndrome.
  5. Sex-biasing influence of autism-associated Ube3a gene overdosage at connectomic, behavioral, and tra…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Angelman Syndrome (AS) Biomarker Study
  2. A Clinical Study Evaluating the Efficacy and Safety of Retinoic Acid in Patients With 15q11-q13 Dupl…
  3. Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome
  4. Study on the Brain Network of Angelman Syndrome
  5. Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.